News from american society of hematology A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Dec 04, 2019, 11:21 ET First Industry Datasets Submitted to ASH Research Collaborative Data Hub

The ASH Research Collaborative (ASH RC) has collaborated with two industry leaders, Novartis Pharmaceuticals Corporation (Novartis) and Amgen, to...


Dec 03, 2019, 16:30 ET ASH Releases New Clinical Practice Guidelines on Immune Thrombocytopenia

Today, ASH published new state-of-the art guidelines on the treatment of immune thrombocytopenia (ITP), a rare blood disorder characterized by a...


Dec 21, 2018, 11:03 ET Study: Increased risk of heart attack, stroke in months leading up to a cancer diagnosis

Older adults with cancer are more likely to have had a heart attack or stroke in the months prior to their cancer diagnosis compared with similar...


Dec 20, 2018, 10:29 ET Blood Editors Announce Top 10 Manuscripts of 2018

The editors of Blood, the most-cited journal in hematology, have selected the top manuscripts of 2018. "These 10 publications were chosen from the...


Dec 17, 2018, 13:29 ET Sutimlimab Shows Promise for Hard-to-Treat, Rare Blood Disorder

In a first-in-human clinical trial reported today in Blood, the investigational drug sutimlimab appeared to be effective in treating cold agglutinin...


Dec 03, 2018, 15:19 ET CAR T-Cell Therapies Show Durable Responses, New Research Also Explores Combination Therapies to Extend and Enhance Treatment Responses

Chimeric antigen receptor (CAR) T-cell therapies have quickly shifted the treatment paradigm for many people with several types of aggressive blood...


Dec 02, 2018, 11:00 ET Studies Offer Glimpses into the Future of Medicine

Today during the 60th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, presenters of three studies will highlight how ...


Dec 01, 2018, 12:30 ET Major Trials Show Benefits of New Therapy Regimens for Cancer and Blood Disorders

Today during the 60th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, researchers will present the results of four...


Dec 01, 2018, 10:30 ET Studies Show Improved Sickle Cell Disease Outcomes Worldwide

Today at the 60th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, researchers will announce findings from four...


Nov 28, 2018, 10:00 ET Platelets Grown from Stem Cells May be Alternative to Donated Platelets

Researchers have developed a way to grow human platelets in the laboratory from stem cells derived from fat tissue. The achievement, reported today...


Nov 15, 2018, 16:18 ET ASH Establishes ASH Research Collaborative to Accelerate Progress in Hematology

The American Society of Hematology has established the ASH Research Collaborative (ASH RC), a mission-focused nonprofit organization that will foster ...


Sep 12, 2018, 14:06 ET American Society of Hematology to Launch Sickle Cell Disease Clinical Trials Network

The American Society of Hematology (ASH) is launching a sickle cell disease (SCD) clinical trials network in order to accelerate the development of...


Jun 21, 2018, 10:17 ET ASH to Collaborate on Clinical Practice Guidelines on Diagnosis, Management of von Willebrand Disease

The American Society of Hematology (ASH) will collaborate with the International Society on Thrombosis and Haemostasis (ISTH), National Hemophilia...


Jun 19, 2018, 11:00 ET On World Sickle Cell Day, ASH Takes Action to Improve Global Health Outcomes

This year, approximately 300,000 babies around the world will be born with sickle cell disease (SCD), an inherited, chronic blood disorder which can...


Jun 15, 2018, 01:20 ET JAK Inhibitors Associated with Aggressive Lymphoma

Austrian researchers have discovered that a small number of patients taking targeted drugs known as Janus kinase (JAK) inhibitors to treat...


Dec 12, 2017, 06:30 ET Late-Breaking Clinical Trials Signal New Therapeutic Options for Many Patients in the Near Term

In four clinical trials being presented today during the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta,...


Dec 11, 2017, 15:30 ET People Aged 75 Years and Older Are Underrepresented in Blood Cancer Clinical Trials

In the first comprehensive analysis of clinical trial enrollment among older adults with blood cancers, researchers from the U.S. Food and Drug...


Dec 11, 2017, 15:26 ET Transfusion Dependence a Barrier to Quality End-of-Life Care for Some Patients with Leukemia

For patients with advanced leukemia, access to high-quality end-of-life care appears to be reduced in those dependent on blood transfusions,...


Dec 10, 2017, 09:30 ET CAR T-Cell Therapies Drive Outcomes in Lymphoma, Myeloma

For people with certain types of aggressive, refractory blood cancers, treatment options are woefully limited. But three studies being presented...


Dec 10, 2017, 07:48 ET Targeted Therapies Show Promise for Improving Outcomes Across a Spectrum of Hematologic Malignancies

Four studies being presented today at the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta highlight the multiple...


Dec 09, 2017, 09:00 ET Bioengineering and Specialized Therapies Yield Results for Rare and Challenging Blood Diseases

In four studies being presented today during the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta, researchers...


Dec 09, 2017, 08:43 ET New Therapies Improve Outlook for Bleeding and Clotting Disorders

In three studies being presented today during the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta, researchers...


Dec 05, 2017, 14:22 ET American Society of Hematology Honors Joe Biden and Tom Brokaw for Their Advocacy for Hematology Research

The American Society of Hematology (ASH) will recognize former Vice President Joseph R. Biden, Jr. and American television journalist and author Tom...


Jun 21, 2017, 12:48 ET New Antibody Uses One-Two Punch to Potentially Treat Blood Cancers

Researchers have developed a two-pronged approach to blood cancer treatment: 1) attacking cancer cells directly and/or 2) driving them from the...


Jun 19, 2017, 12:13 ET ASH to Develop Clinical Guidelines to Improve Care for People with Sickle Cell Disease

This World Sickle Cell Day, the American Society of Hematology (ASH) is working on several projects to conquer sickle cell disease (SCD) worldwide....